Clinical Trials Logo

Stenosis clinical trials

View clinical trials related to Stenosis.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05583305 Enrolling by invitation - Stenosis Clinical Trials

Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome

ICAS_APS
Start date: October 12, 2022
Phase:
Study type: Observational

Antiphospholipid syndrome (APS) is an important cause of young stroke which could result in major disability. Cohort studies suggested that 17% of young ischemic stroke were accountable by APS (1). Although warfarin has been the mainstay of treatment in APS for the past decades, recurrent thromboembolism occurred up to 10% of warfarinized patients with APS (2, 3). These observations call for an in-depth understanding of disease mechanisms secondary to antiphospholipid antibodies (aPL). Contrary to traditional understanding, recent evidence suggested mechanisms of cerebrovascular ischemia in APS are far more complex than hypercoagulability alone. In the proposed cross-sectional study, we aim to determine the prevalence of intracranial stenosis, and to explore the correlations between the neuroimaging findings and the immunological as well as clinical features in patients with APS. In the proposed cross-sectional study, we aim to determine the prevalence of intracranial stenosis, and to explore the correlations between the neuroimaging findings and the immunological as well as clinical features in patients with APS.